Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study von Oliveira-Maia, Albino J, Rive, Benoît, Godinov, Yordan, Mulhern-Haughey, Siobhán

Volltext

Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression:... von Oliveira-Maia, Albino J, Rive, Benoit, Morrens, Joachim, Godinov, Yordan, Cabrieto, Jedelyn, Perualila, Nolen, Mulhern-Haughey, Siobhán

Volltext

ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in... von Oliveira-Maia, Albino J, Morrens, Joachim, Rive, Benoit, Godinov, Yordan, Cabrieto, Jedelyn, Perualila, Nolen, Barbreau, Sebastien, Mulhern-Haughey, Siobhán

Volltext

Esketamine Nasal Spray versus Quetiapine for Resistant Depression. Reply von Reif, Andreas, Mulhern-Haughey, Siobhán, Godinov, Yordan

Volltext

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression von Reif, Andreas, Bitter, Istvan, Buyze, Jozefien, Cebulla, Kerstin, Frey, Richard, Fu, Dong-Jing, Ito, Tetsuro, Kambarov, Yerkebulan, Llorca, Pierre-Michel, Oliveira-Maia, Albino J., Messer, Thomas, Mulhern-Haughey, Siobhán, Rive, Benoît, von Holt, Christian, Young, Allan H., Godinov, Yordan

Volltext

Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial von McIntyre, Roger S, Mattingly, Gregory, Godinov, Yordan, Buyze, Jozefine, Turkoz, Ibrahim, Cabrera, Patricia, Patel, Manish, Martinez, Larry, Himedan, Mai, Lopena, Oliver

Volltext

Esketamine Nasal Spray versus Quetiapine for Resistant Depression von Horowitz, Mark A., Plöderl, Martin, Naudet, Florian, Lan, Chiao-Hsin, Wei, James C.-C., Reif, Andreas, Mulhern-Haughey, Siobhán, Godinov, Yordan

Volltext

Adverse Event Duration with Esketamine Versus Quetiapine XR in Adults With Treatment-Resistant Depression: A Subgroup Analysis of ESCAPE-TRD von Mattingly, Greg, Godinov, Yordan, Buyze, Jozefien, Turkoz, Ibrahim, Cabrera, Patricia, Lopena, Oliver, Sliwa, Jennifer Kern, Brown, Brianne

Volltext

Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression von McIntyre, Roger S., Bitter, Istvan, Buyze, Jozefien, Fagiolini, Andrea, Godinov, Yordan, Gorwood, Philip, Ito, Tetsuro, Oliveira-Maia, Albino J., Vieta, Eduard, Werner-Kiechle, Tamara, Young, Allan H., Reif, Andreas

Volltext

Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial von Young, Allan H, Llorca, Pierre-Michel, Fagiolini, Andrea, Falkai, Peter, Cardoner, Narcís, Nielsen, René E, Blomqvist, Ola, Godinov, Yordan, Rive, Benoît, Diels, Joris, Mulhern-Haughey, Siobhán, Reif, Andreas

Volltext